Figure 1.
PS is localized in the inner membrane leaflet of murine B cells and exposed on stimulation. (A) Lymphocytes from C57BL/10 mice were labeled with anti-CD4APC (T-cell-specific) and anti-CD19PERCP (B-cell-specific) antibodies and preincubated with AVFITC. (Ai) Density plots of the rate of PS exposure (binding of AV) by T cells (CD4+; left panel) and B cells (CD19+; right panel) following stimulation with 5 μM calcimycin (arrows). (Aii) PS exposure by T- and B-cell populations following stimulation. Data are from the experiment shown in panel Ai, plotted as histograms to compare AV binding by cell populations gated at t = 0 seconds (black line) and t = 500 seconds (gray line) in T cells (left panel) and B cells (right panel). (B) Lymphocytes from C57BL/10 mice were labeled with anti-CD19PERCP (B-cell-specific) antibodies, preincubated with AVFITC and stimulated with calcimycin at the doses shown. Density plots illustrate the rate and degree of PS exposure (AV binding). (C) Spontaneous PS exposure and cell death in B-lymphocyte populations ex vivo. Lymphocytes from C57BL/10 mice were labeled with anti-CD4CYCHROME and anti-CD19APC antibodies, to distinguish T and B cells, and incubated with AVFITC. (Ci) Histograms show PS exposure (AV binding) by T cells (CD4+) and B cells (CD19+)30 minutes (black lines) and 2 hours (gray lines) after animals were killed. (Cii) Line graph shows the proportion (± SD) of cells stained with anti-CD19 antibody (B cells) within “live cell” gates as determined by forward and side light scatter at times shown following the time the animals were killed.